The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the JYNNEOS vaccine to allow healthcare providers to use the vaccine for individuals 18 years and older who are determined to be at high risk for monkeypox infection.
Visit the Centers for Disease Control and Prevention (CDC) for more information, in English and Spanish, on monkeypox.
The latest covid-19 surge, caused by a shifting mix of quickly evolving omicron subvariants, appears to be waning, with cases and hospitalizations beginning to fall.
Like past covid waves, this one will leave a lingering imprint in the form of long covid, an ill-defined catchall term for a set of symptoms that can include debilitating fatigue, difficulty breathing, chest pain, and brain fog.
Although omicron infections are proving milder overall than those caused by last summer’s delta variant, omicron has also proved capable of triggering long-term symptoms and organ damage. But whether omicron causes long covid symptoms as often — and as severe — as previous variants is a matter of heated study.
Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, is among the researchers who say the far greater number of omicron infections compared with earlier variants signals the need to prepare for a significant boost in people with long covid. The U.S. has recorded nearly 38 million covid infections so far this year, as omicron has blanketed the nation. That’s about 40% of all infections reported since the start of the pandemic, according to the Johns Hopkins University Coronavirus Research Center.
Long covid “is a parallel pandemic that most people aren’t even thinking about,” said Akiko Iwasaki, a professor of immunobiology at Yale University. “I suspect there will be millions of people who acquire long covid after omicron infection.”
The Washington State Department of Health (DOH) has released its updated COVID-19 guidance for K-12 schools and child care. The guidance takes lessons learned from the first two and a half years of the pandemic, and outlines both required and recommended measures for the 2022-23 school year to help reduce COVID-19 transmission in school and child care settings. Schools, child care providers, and families can expect limited changes focused on clarifying and simplifying the guidance.
“We are entering a new stage of coexisting with COVID-19 in our communities, knowing that COVID-19 is here to stay for the foreseeable future,” said Umair A. Shah, MD, MPH, Secretary of Health. “DOH also recognizes the importance of being able to maintain in-person learning for children, and the fundamental links between education and long-term health outcomes.”
Clarified requirements and recommendations in this school year’s guidance include:
DOH continues to encourage schools and child care providers to consider their local context when selecting any additional measures to help reduce COVID-19 transmission in schools and child care settings and to coordinate with their LHJ, particularly during times of outbreak. Schools, child care providers, and the LHJ may choose to continue to implement more protective measures, depending upon their context, to help ensure students, children, and staff can continue in-person activities safely.
While the guidance is specific to COVID-19 prevention, it can also help to reduce transmission of other common respiratory viruses such as influenza. DOH has also developed a brief for schools and a brief for child care providers to provide a high-level overview on changes to the guidance.
COVID-19 vaccinations remain the best protection for everyone against hospitalization and severe disease from COVID-19. The COVID-19 vaccine is now available for children 6 months and older. Booster doses are also available for children 5 years and older. DOH encourages all families to vaccinate their children if they are eligible, in consultation with health care providers.
988 is the new, nationwide, three-digit dialing code for the Suicide and Crisis Lifeline. The 988 dialing code connects people via call, text, or chat, to the existing National Suicide Prevention Lifeline (NSPL) where compassionate, accessible care and support are available for anyone experiencing mental health-related distress. 988 is the newest addition to the state’s network of crisis center providers and will not replace any crisis call centers in Washington. The current NSPL number, 1-800-273-TALK (8255), will remain active along with the new 988 dialing code.
“Thanks to the many partner organizations and agencies who have made this resource possible,” said Governor Jay Inslee. “In the same way 911 transformed our ability to respond to emergency safety or health situations, 988 will transform our ability to connect people to help in behavioral and mental health crisis situations.”
“Providing an easy-to-remember, three-digit number is an important step to accessing potentially life-saving support,” said Umair A. Shah, MD, MPH, Secretary of Health. “We are dedicated to enhancing and expanding behavioral health crisis response and suicide prevention services for all Washingtonians.”
In addition to activating a new dialing code for anyone experiencing suicidal or mental health-related crisis to call, the 988 Suicide and Crisis Lifeline also allows text messaging as part of increasing access to services for youth and individuals with different abilities. People can also dial or text 988 if they are worried about a loved one who may need crisis support. 988 will be available 24/7 and is free and confidential.
Call services will be available in Spanish, along with interpretation services in over 250 languages. Spanish speakers may reach the Spanish Language Line by pressing 2 after dialing 9-8-8 or 1-800-273-TALK (8255). Text and chat services are available in English only.
Veterans and service members may reach the Veterans Crisis Line by pressing 1 after dialing 9-8-8 or 1-800-273-TALK (8255). Soon, Washington will also be able to launch a Native and Strong Lifeline, dedicated to serving Washington’s American Indian and Alaska Native individuals.
People who are deaf, hard of hearing, and TTY users should use your preferred relay service or dial 711 then 1-800-273-8255.
To increase access to potentially life-saving medication to treat COVID-19, the Washington State Department of Health (DOH) and its partners have launched a new telehealth option for patients. The new option expands the Federal government’s Test to Treat initiative and gives people at risk of severe disease another way to quickly access free treatment for COVID-19.
Until now, telehealth for COVID-19 has only been available to insured patients who receive care through a health care provider that offers telehealth visits. This new program makes telehealth consultations for COVID-19 available to everyone, regardless of insurance status, with no out-of-pocket costs.
“At DOH, we value equity and innovation, and have embraced those values throughout our COVID-19 response,” said Umair A. Shah, MD, MPH, Secretary of Health. “Ensuring that we can equitably connect communities with therapeutics is pivotal so that we can continue our mission of reducing unnecessary death from this disease.”
DOH encourages people who test positive for COVID-19 to discuss treatment options with their primary health care provider. In situations where this might not be possible, free telehealth consultations are another option that can make it even easier to access treatments for COVID-19. People who test positive for COVID-19, including with a self-test, can consult with a health care provider using a smartphone or computer with a high-speed internet connection.
If appropriate, they can receive a free prescription for pick-up at the nearest pharmacy that has the oral antivirals or have their medication delivered. More than 1,000 sites are available across the state. This telehealth service is currently provided by DOH in collaboration with partners, including Birds Eye Medical and Color Health.
There are two options to set up a telehealth appointment – either by visiting DOH’s new telehealth webpage or by calling the DOH COVID-19 call center. Those interested in signing up virtually can complete a brief intake form on DOH’s new telehealth webpage. If the information provided indicates treatment may be appropriate, the patient will be connected virtually with a health care provider for a consultation. Telehealth providers are available every day from 8 a.m. to 8 p.m.
Those interested can arrange an appointment by phone by calling the DOH COVID-19 call center at 1–800–525–0127 and press #. The call center is available to arrange telehealth consultations from 8 a.m. to 8 p.m. on Mondays, and 8 a.m. to 6 p.m. on Tuesdays through Sundays and state holidays.
Telehealth appointments are currently available in 240 languages through translation services. People interested in receiving a telehealth appointment in a language other than English should arrange an appointment through the DOH COVID-19 call center.
One of the most effective COVID-19 treatments is Paxlovid, an oral antiviral drug that reduces the risk of hospitalization by approximately 90 percent. Oral antivirals like Paxlovid are only available by prescription and must be started within five days of first symptoms to prevent severe illness and hospitalization from COVID-19.
“Our goal is for all eligible patients at high risk for severe disease to have equitable access to life-saving COVID-19 treatments,” said Tao Sheng Kwan-Gett, MD, MPH, Chief Science Officer. “We’re excited to make this service free to everyone with no out of pocket costs so that even those without insurance will be able to access antiviral medications. And by offering telehealth consultations in multiple languages, the program increases access for non-English speakers as well.”
Oral antivirals are an important treatment for people who are at high risk of hospitalization. People at high risk include those 65 years old or older, obese, pregnant, have chronic medical conditions such as heart, lung, or kidney disease, or people who are taking immunosuppressant treatments. Children as young as 12 years old with certain chronic conditions and who weigh at least 88 pounds, may also be eligible for antiviral treatment. Learn more about what may place people at high risk for COVID-19.
Visit the Washington State Department of Health’s website for more information on COVID-19 treatments and information for health care providers.
When Pat Paulson’s son told her he was feeling anxious and depressed at college, Paulson went through her Blue Cross Blue Shield provider directory and started calling mental health therapists. No providers in the Wisconsin city where her son’s university is located had openings. So she bought a monthly subscription to BetterHelp, a Mountain View, California, company that links people to therapists online.
Her son felt uncomfortable with his first BetterHelp therapist. After waiting several weeks, he saw a second therapist, whom he liked. But she wasn’t available the following week.
Despite the switch and the wait, Paulson is grateful she was able to find her son help. “He was getting to the point where he was ready to give up trying to find someone,” she said.
Many U.S. adults aren’t able to find help because of a shortage of therapists. Nearly 40% are struggling with mental health or substance abuse issues, according to the Centers for Disease Control and Prevention.
The World Health Organization said June 25 that monkeypox wasn’t yet a public health emergency of international concern. More than 4,500 cases have been reported worldwide, with more than 300 in the U.S. And with public health officials unable to follow all chains of transmission, they’re likely undercounting cases. Everyone should be aware of its symptoms, how it spreads, and the risks of it getting worse.
Q: Should I be worried about monkeypox?
The American public is currently at low risk for monkeypox. It is spreading among men who have sex with men, but it is only a matter of time before it spreads to others. As of June 27, the European Centre for Disease Prevention and Control had reported 10 cases among women. Monkeypox is generally a mild disease but can be serious or even deadly for people who are immunocompromised, pregnant women, a fetus or newborn, women who are breastfeeding, young children, and people with severe skin diseases such as eczema.
But monkeypox could become endemic in the U.S. and around the world if it continues to spread unchecked.
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation that all children 6 months through 5 years of age should receive a COVID-19 vaccine. This expands eligibility for vaccination to nearly 20 million additional children and means that all Americans ages 6 months and older are now eligible for vaccination.
Parents and caregivers can now get their children 6 months through 5 years of age vaccinated with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. All children, including children who have already had COVID-19, should get vaccinated.
COVID-19 vaccines have undergone—and will continue to undergo—the most intensive safety monitoring in U.S. history. Parents and caregivers can play an active role in monitoring the safety of these vaccines by signing their children up for v-safe – personalized and confidential health check-ins via text messages and web surveys where they can easily share with CDC how a child feels after getting a COVID-19 vaccine.
Distribution of pediatric vaccinations for these younger children has started across the country, and will be available at thousands of pediatric practices, pharmacies, Federally Qualified Health Centers, local health departments, clinics, and other locations this week. Children in this younger age group can be vaccinated with whichever vaccine is available (either Moderna or Pfizer-BioNTech). Parents can reach out to their doctor, nurse, local pharmacy, or health department, or visit vaccines.gov to see where vaccines for children are available.
OLYMPIA – The Washington State Department of Health (DOH), in partnership with the Washington State Blood Coalition, is encouraging eligible donors to give blood this summer.
In addition to celebrating World Blood Donor Day on June 14, blood centers in Washington state are preparing for the summer months ahead—which is a critical time for blood donations.
“Blood donations usually start to drop around this time of year due to summer schedule and vacations,” said Curt Bailey, President and Chief Executive Officer, Bloodworks Northwest. “But we need everyone’s help to keep our blood supply stable for those who need it.”
The call for donations this summer is especially urgent due to an ongoing nationwide blood shortage. Earlier this year the American Red Cross announced a blood crisis, citing its worst blood shortage in over a decade. Governor Jay Inslee and Umair A. Shah, MD, MPH, Secretary of Health, have urged people in Washington to donate blood if able to do so.
“Donating blood is a safe activity that can save lives,” said Andrew Rose, COVID-19 Incident Commander, Washington State Department of Health, whose team in the Office of Emergency Preparedness, Resilience and Response meets regularly with local blood centers to monitor safety and supply. All types of blood are needed for cancer treatment, trauma cases, and many other situations. A donation appointment usually takes less than an hour and includes a donor screening process to evaluate each person’s temperature, current health and travel history. Actual donation time is about 10 minutes.
“Our primary focus is to ensure a safe and reliable blood supply in our community,” says Angel Montes, Regional Donor Services Executive, American Red Cross, explaining the blood center coalition’s call to action. Christine Swinehart, Executive Director, Cascade Regional Blood Services, added, “We know that people care and will step up when they learn how important the need is. We’re here to make the process as easy as possible.”
More information about donating blood, including how to schedule an appointment and updates related to COVID-19, is available from local blood centers: